Does LANADELUMAB-FLYO Cause Injection site erythema? 44 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 44 reports of Injection site erythema have been filed in association with LANADELUMAB-FLYO. This represents 3.0% of all adverse event reports for LANADELUMAB-FLYO.
44
Reports of Injection site erythema with LANADELUMAB-FLYO
3.0%
of all LANADELUMAB-FLYO reports
1
Deaths
17
Hospitalizations
How Dangerous Is Injection site erythema From LANADELUMAB-FLYO?
Of the 44 reports, 1 (2.3%) resulted in death, 17 (38.6%) required hospitalization, and 2 (4.5%) were considered life-threatening.
Is Injection site erythema Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for LANADELUMAB-FLYO. However, 44 reports have been filed with the FAERS database.
What Other Side Effects Does LANADELUMAB-FLYO Cause?
Hereditary angioedema (794)
Product dose omission issue (177)
Inappropriate schedule of product administration (144)
Drug ineffective (137)
Headache (126)
Weight decreased (125)
Weight increased (120)
Injection site pain (119)
Product use issue (114)
Malaise (90)
What Other Drugs Cause Injection site erythema?
ETANERCEPT (17,736)
DUPILUMAB (8,818)
ADALIMUMAB (8,563)
TIRZEPATIDE (3,844)
TERIPARATIDE (3,453)
GLATIRAMER (2,560)
IXEKIZUMAB (2,144)
ENBREL (1,879)
EVOLOCUMAB (1,754)
HUMIRA (1,654)
Which LANADELUMAB-FLYO Alternatives Have Lower Injection site erythema Risk?
LANADELUMAB-FLYO vs LANREOTIDE
LANADELUMAB-FLYO vs LANSOPRAZOLE
LANADELUMAB-FLYO vs LANTHANUM
LANADELUMAB-FLYO vs LANTUS
LANADELUMAB-FLYO vs LANTUS SOLOSTAR